Quality control on digital cancer registration

PLoS One. 2022 Dec 22;17(12):e0279415. doi: 10.1371/journal.pone.0279415. eCollection 2022.

Abstract

Population-based cancer registration methods are subject to internationally-established rules. To ensure efficient and effective case recording, population-based cancer registries widely adopt digital processing (DP) methods. At the Veneto Tumor Registry (RTV), about 50% of all digitally-identified (putative) cases of cancer are further profiled by means of registrars' assessments (RAs). Taking these RAs for reference, the present study examines how well the registry's DP performs. A series of 1,801 (putative) incident and prevalent cancers identified using DP methods were randomly assigned to two experienced registrars (blinded to the DP output), who independently re-assessed every case. This study focuses on the concordance between the DP output and the RAs as concerns cancer status (incident versus prevalent), topography, and morphology. The RAs confirmed the cancer status emerging from DP for 1,266/1,317 incident cancers (positive predictive value [PPV] = 96.1%) and 460/472 prevalent cancers (PPV = 97.5%). This level of concordance ranks as "optimal", with a Cohen's K value of 0.91. The overall prevalence of false-positive cancer cases identified by DP was 2.9%, and was affected by the number of digital variables available. DP and the RAs were consistent in identifying cancer topography in 88.7% of cases; differences concerned different sites within the same anatomo-functional district (according to the International Agency for Research on Cancer [IARC]) in 9.6% of cases. In short, using DP for cancer case registration suffers from only trivial inconsistencies. The efficiency and reliability of digital cancer registration is influenced by the availability of good-quality clinical information, and the regular interdisciplinary monitoring of a registry's DP performance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Neoplasms* / epidemiology
  • Neoplasms* / pathology
  • Prevalence
  • Quality Control
  • Registries
  • Reproducibility of Results

Grants and funding

The study was supported by the Italian Ministry of Health, "Bando per la ricerca finalizzata 2016 (RF-2016-02364635), Increasing the effectiveness of cancer registration: development of automatic procedures, use of new data sources, recording of cancer biomarkers. The ACRA study (Advanced Cancer Registry Automation)". https://www.salute.gov.it/imgs/C_17_bandi_135_listaFile_itemName_9_file.pdf The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SG.